To examine whether EZH2 regulates transitions between the epithelial and mesenchymal states of breast cancer cells we setup an in vitro system to study the dynamics of EMT and its reverse process (mesenchymal to epithelial transition, MET) (Fig. 2A). Here, EZH2 is linked to breast cancer.